48832 Federal Register / Vol. 82, No. 202 / Friday, October 20, 2017 / Notices 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3192, 

MSC 7808, Bethesda, MD 20892, 301–435– 

1149, marci.scidmore@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR: 

Development of Appropriate Pediatric 

Formulations and Pediatric Drug Delivery 

Systems. 

Date: November 17, 2017. 

Time: 2:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Arlington Pentagon 

City, 550 Army Navy Drive, Arlington, VA 

22202. 

Contact Person: Joseph G. Rudolph, Ph.D., 

Chief and Scientific Review Officer, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5186, 

MSC 7844, Bethesda, MD 20892, 301–408– 

9098, josephru@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: October 13, 2017. 

Anna Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–22725 Filed 10–19–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Charter Renewal 

It is determined that the National 

Cancer Institute Board of Scientific 

Advisors is in the public interest in 

connection with the performance of 

duties imposed on the National Cancer 

Institute and National Institutes of 

Health by law, and that these duties can 

best be performed through the advice 

and counsel of this group. 

In accordance with Title 41 of the 

U.S. Code of Federal Regulations, 

Section 102–3.65(a), notice is hereby 

given that the Charter for the National 

Cancer Institute Board of Scientific 

Advisors was renewed for an additional 

two-year period on October 8, 2017. 

Inquiries may be directed to Anna 

Snouffer, Acting Director, Office of 

Federal Advisory Committee Policy, 

Office of the Director, National 

Institutes of Health, 6701 Democracy 

Boulevard, Suite 1000, Bethesda, 

Maryland 20892 (Mail code 4875), 

Telephone (301) 496–2123, or 

snouffea@od.nih.gov. 

Dated: October 17, 2017. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–22824 Filed 10–19–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Evaluation and Testing 

Services for Vaccines and Other Biologics for 

Diseases (N01). 

Date: November 14, 2017. 

Time: 12:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 5601 

Fishers Lane, Rockville, MD 20892 

(Telephone Conference Call). 

Contact Person: Annie Walker-Abbey, 

Ph.D., Scientific Review Officer, Scientific 

Review Program, NIAID/NIH/DHHS, 5601 

Fishers Lane, Room 3E70A, Rockville, MD 

20852, 240–627–3390, aabbey@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: October 17, 2017. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–22825 Filed 10–19–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Initial Review Group; Subcommittee 

A—Cancer Centers. 

Date: November 30–December 1, 2017. 

Time: 6:00 p.m. to 2:25 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Cambria Suites Rockville, 1 Helen 

Heneghan Way, Rockville, MD 20850. 

Contact Person: Shamala K. Srinivas, 

Ph.D., Scientific Review Officer, Office of 

Referral, Review, and Program Coordination, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W530, Bethesda, MD 20892– 

9750, 240–276–6442, ss537t@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel Cancer 

Center Support Grant (P30). 

Date: December 1, 2017. 

Time: 2:30 p.m. to 4:15 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Cambria Suites, Rockville, 1 Helen 

Heneghan Way, Rockville, MD 20850. 

Contact Person: Adriana Stoica, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W234, Bethesda, MD 20892–9750, 

240–276–6368, Stoicaa2@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: October 16, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–22729 Filed 10–19–17; 8:45 am] 

BILLING CODE 4140–01–P 


srobinson on DSKBC5CHB2PROD with NOTICES